{"entity":{"type":"insider","cik":"0001920509","url":"/insider/0001920509","json_url":"/insider/0001920509.json","name":"Santos da Silva Jorge","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":7,"first":"2024-02-20","last":"2026-07-13","span_basis":"filed_date"},"name_variants":[{"name":"Santos da Silva Jorge","source":"filing","n_filings":7,"first_seen":"2024-02-20","last_seen":"2026-07-13"}],"transactions":[{"id":5826286,"accession":"0001213900-26-077564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-077564","line_url":"/filing/0001213900-26-077564#line-2","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68289.0,"shares_display":"68,289","price_per_share":20.02,"price_display":"20.02","price_state":"stated","total_value":1367145.78,"total_display":"1,367,145.78","total_whole":"1,367,146","shares_owned_after":2774893.0,"shares_owned_after_display":"2,774,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-10","filed_date":"2026-07-13","scope":"insider"},{"id":5826284,"accession":"0001213900-26-077564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-077564","line_url":"/filing/0001213900-26-077564#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33936.0,"shares_display":"33,936","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":679059.36,"total_display":"679,059.36","total_whole":"679,059","shares_owned_after":2843182.0,"shares_owned_after_display":"2,843,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-13","scope":"insider"},{"id":5798861,"accession":"0001213900-26-074964","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-074964","line_url":"/filing/0001213900-26-074964#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47775.0,"shares_display":"47,775","price_per_share":20.03,"price_display":"20.03","price_state":"stated","total_value":956933.25,"total_display":"956,933.25","total_whole":"956,933","shares_owned_after":2877118.0,"shares_owned_after_display":"2,877,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider"},{"id":6018609,"accession":"0001213900-26-043647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-26-043647","line_url":"/filing/0001213900-26-043647#line-2","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51873.0,"shares_display":"51,873","price_per_share":18.23,"price_display":"18.23","price_state":"stated","total_value":945644.79,"total_display":"945,644.79","total_whole":"945,645","shares_owned_after":2924893.0,"shares_owned_after_display":"2,924,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-13","filed_date":"2026-04-14","scope":"insider"},{"id":6018606,"accession":"0001213900-26-043647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-26-043647","line_url":"/filing/0001213900-26-043647#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98127.0,"shares_display":"98,127","price_per_share":18.41,"price_display":"18.41","price_state":"stated","total_value":1806518.07,"total_display":"1,806,518.07","total_whole":"1,806,518","shares_owned_after":2976766.0,"shares_owned_after_display":"2,976,766","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-10","filed_date":"2026-04-14","scope":"insider"},{"id":4094564,"accession":"0001213900-25-120106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-120106","line_url":"/filing/0001213900-25-120106#line-2","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70000.0,"shares_display":"70,000","price_per_share":14.49,"price_display":"14.49","price_state":"stated","total_value":1014300.0,"total_display":"1,014,300.00","total_whole":"1,014,300","shares_owned_after":2878577.0,"shares_owned_after_display":"2,878,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-10","scope":"insider"},{"id":4094560,"accession":"0001213900-25-120106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-120106","line_url":"/filing/0001213900-25-120106#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130000.0,"shares_display":"130,000","price_per_share":15.08,"price_display":"15.08","price_state":"stated","total_value":1960400.0,"total_display":"1,960,400.00","total_whole":"1,960,400","shares_owned_after":2948577.0,"shares_owned_after_display":"2,948,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":2982451,"accession":"0001213900-24-018675","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-018675","line_url":"/filing/0001213900-24-018675#line-3","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4740.0,"shares_display":"4,740","price_per_share":55.89,"price_display":"55.89","price_state":"stated","total_value":264918.6,"total_display":"264,918.60","total_whole":"264,919","shares_owned_after":2982814.0,"shares_owned_after_display":"2,982,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-02-29","scope":"insider"},{"id":2982446,"accession":"0001213900-24-018675","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-018675","line_url":"/filing/0001213900-24-018675#line-2","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56065.0,"shares_display":"56,065","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":3083575.0,"total_display":"3,083,575.00","total_whole":"3,083,575","shares_owned_after":2987554.0,"shares_owned_after_display":"2,987,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider"},{"id":2982443,"accession":"0001213900-24-018675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-018675","line_url":"/filing/0001213900-24-018675#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62810.0,"shares_display":"62,810","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":3454550.0,"total_display":"3,454,550.00","total_whole":"3,454,550","shares_owned_after":3043619.0,"shares_owned_after_display":"3,043,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":2591530,"accession":"0001213900-24-016544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-016544","line_url":"/filing/0001213900-24-016544#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":55.27,"price_display":"55.27","price_state":"stated","total_value":62178.75,"total_display":"62,178.75","total_whole":"62,179","shares_owned_after":3106429.0,"shares_owned_after_display":"3,106,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-23","scope":"insider"},{"id":2151769,"accession":"0001213900-24-015446","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-015446","line_url":"/filing/0001213900-24-015446#line-3","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":57.44,"price_display":"57.44","price_state":"stated","total_value":1148800.0,"total_display":"1,148,800.00","total_whole":"1,148,800","shares_owned_after":3107554.0,"shares_owned_after_display":"3,107,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-20","scope":"insider"},{"id":2151765,"accession":"0001213900-24-015446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-015446","line_url":"/filing/0001213900-24-015446#line-2","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":60.15,"price_display":"60.15","price_state":"stated","total_value":1203000.0,"total_display":"1,203,000.00","total_whole":"1,203,000","shares_owned_after":3127554.0,"shares_owned_after_display":"3,127,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-20","scope":"insider"},{"id":2151760,"accession":"0001213900-24-015446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-015446","line_url":"/filing/0001213900-24-015446#line-1","is_derivative":false,"issuer_cik":"0001821586","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001821586","owner_cik":"0001920509","owner_name":"Santos da Silva Jorge","owner_display_name":"Santos da Silva Jorge","owner_url":"/insider/0001920509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A ordinary shares, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":60.18,"price_display":"60.18","price_state":"stated","total_value":1203600.0,"total_display":"1,203,600.00","total_whole":"1,203,600","shares_owned_after":3147554.0,"shares_owned_after_display":"3,147,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001821586","name":"MoonLake Immunotherapeutics","url":"/issuer/0001821586","role":"Director, Officer (Chief Executive Officer)","n_filings":7,"first_seen":"2024-02-20","last_seen":"2026-07-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001920509","retrieved_at":"2026-08-27T03:42:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}